The most important financial indicators for the company Ipsen Pharma Romania S.r.l. - Unique Identification Number 39002554:
sales in 2023 was
44.368.788
euro, registering a net profit of
617.134
euro and having an average number of
43
employees.
Firma isi desfasoara activitatea in domeniul Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
In the last year of activity, the sales increased by 29.3%, from 34.430.694 euro in the year 2022, to 44.368.788 euro in 2023.
The Net Profit increased by 42.534 euro, from 576.348 euro in 2022, to 617.134 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Ipsen Pharma Romania S.r.l. - CUI 39002554
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
-
-
41.829
47.901
93.115
70.335
91.505
79.603
Current Assets
-
-
-
-
968.318
13.796.707
20.171.119
22.595.887
28.694.392
34.146.340
Inventories
-
-
-
-
0
5.193.485
9.422.911
9.087.880
9.624.844
11.616.704
Receivables
-
-
-
-
928.914
6.769.680
8.705.997
11.733.417
18.159.012
20.715.365
Cash
-
-
-
-
39.405
1.833.541
2.042.211
1.774.591
910.536
1.814.271
Shareholders Funds
-
-
-
-
80.848
897.243
2.012.403
3.827.164
4.415.386
5.019.130
Social Capital
-
-
-
-
10.745
10.537
10.337
10.108
10.139
10.108
Debts
-
-
-
-
708.967
12.838.548
18.146.966
18.670.909
24.376.288
29.205.179
Income in Advance
-
-
-
-
0
0
0
0
6.270
11.975
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
34.146.340 euro in 2023 which includes Inventories of
11.616.704 euro, Receivables of
20.715.365 euro and cash availability of
1.814.271 euro.
The company's Equity was valued at
5.019.130 euro, while total Liabilities amounted to
29.205.179 euro.
Equity increased by 617.134 euro, from 4.415.386 euro in 2022, to 5.019.130 in 2023.
The Debt Ratio was 85.3% in the year 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ipsen Pharma Romania S.r.l.